Skip to content

Intrafamilial Transmission of Hepatitis B Virus: Frequency, Risk Factors, and Role of Hepatitis B Vaccination

Intrafamilial Transmission of Hepatitis B Virus: Frequency, Risk Factors, and Role of Hepatitis B Vaccination

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05523921
Enrollment
50
Registered
2022-09-01
Start date
2022-09-01
Completion date
2023-10-01
Last updated
2022-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HBV Transmission

Keywords

Intrafamilial transmission of HBV.

Brief summary

The primary aim of the study is to accomplish two major tasks: the first is to determine the frequency of intra-familial transmission of HBV; the second is trying to explore the potential risk factors of such a transmission .As a secondary aim, immunologic status of the household contacts vaccinated for hepatitis B will be evaluated to assess the efficacy of hepatitis B vaccination and its role in prevention of intra-familial transmission of HBV

Detailed description

Hepatitis B virus (HBV) infection is a global health issue; it is estimated that 257 million persons have chronic HBV (Asgeir et al., 2021). The major routes of HBV transmission include blood, sexual contact, vertical (from infected mothers to her children) and horizontal (between the spouses or children) transmission (Şükran et al., (2018). The household transmission of HBV is also a major health issue; it represents a challenge to the health system. Higher rates of HBV infection were reported among the household contacts of chronic HBV carriers; the prevalence of HBV infection among the family members of patients with chronic HBV can reach to 57%. Factors affecting the risk of transmission include socio-demographic status, family role (infected mothers increase the risk of transmission) and viral markers of the index case (Masomeh et al., 2016).The diagnosis of HBV infection is generally based on serological (hepatitis B surface antigen) and molecular assays (hepatitis B virus deoxyribonucleic acid) (Chen et al., 2017).Although the three-dose vaccination for hepatitis B provides more than 90% seroprotection rates (Van Den Ende C, et al, 2017); approximately 10% of vaccinated persons may be at risk of getting infected. Available data about the current status of intra-familial transmission of HBV among our community members are lacking; we need to determine the magnitude of such a major public health problem

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years

Inclusion criteria

* : The household contacts of patients with chronic HBV infection will be included in the study.

Exclusion criteria

* Those with prior diagnosis of HBV infection following the date of the primary case infection.

Design outcomes

Primary

MeasureTime frameDescription
Determine the frequency of intra-familial transmission of HBV; & trying to explore the potential risk factors of such a transmission.Baseline.Determine the frequency of intra-familial transmission of HBV; & trying to explore the potential risk factors of such a transmission.

Secondary

MeasureTime frameDescription
To assess the efficacy of hepatitis B vaccination and its role in prevention of intra-familial transmission of HBV.Baseline.To assess the efficacy of hepatitis B vaccination and its role in prevention of intra-familial transmission of HBV.

Contacts

Primary ContactMohammed Faik Hamed, Resident
mohammadfaik9523@gmail.com+201148960065
Backup ContactAhmad Farooq Alsayed, Professor
prof.a.f@yahoo.com+201020288660

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026